With the first ever RNA-based gene-silencing drug approved by FDA, and more investments in the RNA-Targeted Drug Discovery field, the leading drug developers are telling us they are actively searching for contract service providers that have the technical experience, capacity and flexibility to meet their demands.
Senior decision-makers at these leading companies will come together at the 1st RNA-Targeted Drug Discovery Summit in Boston seeking to collaborate with organizations that can help them accelerate their RNA-targeted drug development.
Partnering with the 1st RNA-Targeted Drug Discovery Summit will ensure you capitalize on the market share early, cement your position as an industry leader and benefit from market intelligence.
GET IN TOUCH WITH:
HERE TO HELP YOU PARTICIPATE AND SHOWCASE YOUR SOLUTION AT THE RNA-TDD SUMMIT 2018